Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404596 · ClinicalTrials.gov registry record · Early Phase 1
Applying mHealth to Tobacco-related Health Disparities
A Early Phase 1 study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03404596: Completed Early Phase 1 study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT03404596 is a Early Phase 1 study of Smoking Cessation that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 50 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03404596, a Early Phase 1 study of Smoking Cessation, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand what happens when someone attempts to quit smoking.
Primary Outcome
Lapse will be measured objectively and automatically from the equipment worn by participants (AutoSense).
Conditions Studied
Interventions
- BEHAVIORAL Counseling
- DRUG Nicotine Patch
- BEHAVIORAL Smartphone
- OTHER AutoSense
Study Locations (1)
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2020-12-14 |
| Phase | Early Phase 1 |
What the finished NCT03404596 record still lists
NCT03404596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Counseling is the first listed.
NCT03404596 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03404596 about?
NCT03404596 is a clinical study titled "Applying mHealth to Tobacco-related Health Disparities". The purpose of this study is to better understand what happens when someone attempts to quit smoking.
What is the current status of trial NCT03404596?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2018-07-16. Estimated completion is 2020-12-14.
What conditions does trial NCT03404596 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03404596?
The interventions under investigation include: Counseling (BEHAVIORAL), Nicotine Patch (DRUG), Smartphone (BEHAVIORAL), AutoSense (OTHER).
Who is sponsoring clinical trial NCT03404596?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03404596 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03404596's enrollment target sits among peer trials
50 145th of 188 higher than 38 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
End Nicotine Dependence Clinic
COMPLETED · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI